Sinopharm Holding Guangzhou Co. Ltd Signs Up Big Investors for Hong Kong IPO

Published: Sep 02, 2009

ChinoBio Today -- Sinopharm Holdings, a joint venture between China National Pharmaceutical Group and Fosun International, is making progress on its planned $1 billion IPO in Hong Kong. The company announced it has found eight “cornerstone” investors who will together buy 20% of the offering. In exchange for a guaranteed number of shares, the investors pledged to hold their shares for an unspecified period. More details...

Back to news